Macrocytic anemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 15: | Line 15: | ||
}} | }} | ||
{{Macrocytic anemia}} | {{Macrocytic anemia}} | ||
{{CMG}}; '''Associate Editor-In-Chief:''' {{ADS}} {{CZ}} {{OK}} | {{CMG}}; '''Associate Editor-In-Chief:''' {{ADS}}, {{CZ}}, {{OK}} | ||
==[[Macrocytic anemia overview|Overview]]== | ==[[Macrocytic anemia overview|Overview]]== |
Revision as of 14:04, 23 October 2018
For patient information click here
Macrocytic anemia | |
Megaloblastic anemia blood smear | |
ICD-10 | D51.1, D52.0, D53.1 |
ICD-9 | 281 |
MeSH | D000749 |
Macrocytic anemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Macrocytic anemia On the Web |
American Roentgen Ray Society Images of Macrocytic anemia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Amandeep Singh M.D.[2], Cafer Zorkun, M.D., Ph.D. [3], Omer Kamal, M.D.[4]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Macrocytic anemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-ray | Echocardiography and Ultrasound | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies